| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.46 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |